Register for our upcoming webinar:
Target Safety Assessment: from target biology to associated liabilities
10th February 2022 @4pm (GMT) / 11am (EST) / 8am (PST)
In this webinar you will learn about:
- Why invest in Target Safety Assessment Reports: challenges in target safety profiling and target safety-related drug attrition.
- Advantages of utilizing a Full-TSA in your drug development program.
- Overview of a Full-Target Safety Assessment Report.
Who should attend?
Professionals working in: pharmaceutical toxicology, chemical safety, preclinical safety, clinical development, medical biology, molecular biology
Learn about the liabilities that are potentially associated with your target to help accelerate your decision-making processes.
The webinar either no longer exists or an error has occured.